Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / India/  Covaxin Phase 2-3 clinical trials for 2-18 age group to begin in 10-12 days: Govt
BackBack

Covaxin Phase 2-3 clinical trials for 2-18 age group to begin in 10-12 days: Govt

'I have been told that trials will begin in the next 10-12 days,' Dr VK Paul said on Tuesday during a press briefing on Covid-19
  • This is the first time in India that a Covid-19 vaccine will be tested on children
  • Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years.Premium
    Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years.

    The Phase 2-3 clinical trials of Covid-19 vaccine, Covaxin, which has been approved by the Drugs Controller General of India (DCGI), for in the age group of 2 to 18 years, will begin in the coming 10 to 12 days, Dr VK Paul, Member, NITI Aayog said.

    "I have been told that trials will begin in the next 10-12 days," Dr VK Paul said on Tuesday during a press briefing on Covid-19.

    This is the first time in India that a Covid-19 vaccine will be tested on children.

    The clinical trials involve two Covid-19 vaccine shots injected on day 0 and day 28.

    The trials will take place at several sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

    India's drug regulator has accepted the recommendation of the Subject Expert Committee (SEC) and given a nod to the Hyderabad-based Bharat Biotech to conduct Phase II/III clinical trial of Covid-19 vaccine Covaxin in the age group 2 to 18 years.

    Covaxin maker Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers.

    Apart from Covaxin, vaccine maker Serum Institute's Covishield is being used to vaccinate people in the country. Meanwhile, Russia's Covid-19 vaccine Sputnik V is also available at Apollo Hospital at Hyderabad's Jubilee Hills and is being administered only to the beneficiaries who are 45 years or older.

    Reports also suggest that RDIF will soon launch its single-dose vaccine Sputnik V Light in India. "We hope for the introduction of Sputnik V Light in India soon," RDIF CEO Kirill Dmitriev had said.

    Miniscule bleeding, clotting events post-vaccination

    Earlier on Monday, the Union Health Ministry said that over 23,000 adverse events have been reported since the vaccination drive involving Covishield and Covaxin vaccines started in the country and of these 700 cases were reported to be serious.

    The National Adverse Event Following Immunisation committee (AEFI) has completed an in-depth case review of 498 serious and severe events, of which 26 cases have been reported to be potential thromboembolic (formation of a clot in a blood vessel that might also break loose and carried by the blood stream to plug another vessel) events – following administration of Covishield vaccine – "with a reporting rate of 0.61 cases/ million doses".

    "There were no potential thromboembolic events reported following administration of Covaxin vaccine," the ministry added.

    Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

    ABOUT THE AUTHOR
    Meghna Sen
    Business journalist tracking markets, companies, economy and crypto for Livemint. She has 6 years of experience with online and print publications. Email: meghnasen08@gmail.com
    Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
    More Less
    Published: 18 May 2021, 05:45 PM IST
    Next Story footLogo
    Recommended For You
    Switch to the Mint app for fast and personalized news - Get App